Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
주식 순위 #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
주가
$0.00695
마지막 동기화: 2024-10-29
시가총액
$536.40
변동 (1일)
-0.71%
변동 (1년)
0.00%
국가
US
거래 BIOLASE, Inc. (BIOL)

카테고리

BIOLASE, Inc. (BIOL)의 매출
Sep 2024 기준 매출 TTM: $46.03M
BIOLASE, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $46.03M입니다. 2022년에 회사는 $48.46M의 수익을 올렸으며 이는 2021년의 $39.19M 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
BIOLASE, Inc.의 수익 기록 (2000 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $46.03M -6.38%
2023 $49.16M 1.45%
2022 $48.46M 23.67%
2021 $39.19M 72.03%
2020 $22.78M -39.73%
2019 $37.80M -18.10%
2018 $46.16M -1.64%
2017 $46.93M -9.43%
2016 $51.81M 6.88%
2015 $48.48M 1.72%
2014 $47.66M -15.55%
2013 $56.43M -1.61%
2012 $57.36M 17.39%
2011 $48.86M 86.30%
2010 $26.23M -39.50%
2009 $43.35M -32.93%
2008 $64.63M -3.38%
2007 $66.89M -4.03%
2006 $69.70M 12.46%
2005 $61.98M 2.19%
2004 $60.65M 23.57%
2003 $49.08M 68.09%
2002 $29.20M 63.24%
2001 $17.89M 85.22%
2000 $9.66M 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
$46.59B 101,114.53%
US
$25.84B 56,035.66%
US
$35.48B 76,995.55%
IE
$21.00B 45,517.69%
US
$6.51B 14,049.18%
US